PEP++ Stop transmission of Leprosy

Country: India

Location(s): Chandauli, Fatehpur

It is a cluster-randomised controlled trial, with the objective for stopping the transmission of M. leprae in the project intervention areas, by demonstrating the effectiveness and efficacy of the enhanced post-exposure prophylaxis regimen (PEP++) compared to Post Exposure Prophylaxis with Single Dose of Rifampicin (PEP with SDR)

ILEP Members involved

NLR
Ashok Agarwal

The Leprosy Mission
Premal Das

Partners

Vardhman Mahavir Medical College (VMMC) & Safdarjung Hospital, Ministry of Health & Family Welfare, New Delhi

Physical facilities involved

SafdarJung Hospital, New delhi